Emanual Maverakis, MD
University of California, Davis · UC Davis
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Emanual Maverakis, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:52 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05040204 · The Effects of Dietary Supplementation on Serum Protein GlycosylationUniversity of California, Davis · recruiting · Healthy · principal investigator
- Ph1NCT04466761 · Ascending Glycan Dietary Supplementation in Healthy AdultsUniversity of California, Davis · terminated · Healthy Individuals · principal investigator
- Ph3NCT04128176 · Efficacy and Safety of Rituximab Combined With Omalizumab in Patients With Bullous PemphigoidUniversity of California, Davis · withdrawn · Bullous Pemphigoid · principal investigator
- Ph1NCT03437005 · Alternation in the Human Microbiome With Commonly Used Topical MedicationsUniversity of California, Davis · recruiting · Healthy · principal investigator
- Ph1/Ph2NCT02319616 · Topical Clobetasol for the Treatment of Toxic Epidermal NecrolysisUniversity of California, Davis · withdrawn · Toxic Epidermal Necrolysis · principal investigator
- Ph1NCT02286999 · Probiotic Supplementation in Breastfed Newborn InfantsEmanual Maverakis, MD · withdrawn · Atopic Dermatitis, Food Allergies · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Mentoring Translational Scientists in Clinical Trial Immune MonitoringK24AR077313 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Emanual M. Maverakis · fiscal years 2021 to 2025Named on NCT05040204
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.